TMEM45A is essential for hypoxia-induced chemoresistance in breast and liver cancer cells

Genome-wide analysis discloses reversal of the hypoxia-induced changes of gene expression in colon cancer cells by zinc supplementation

(2015) Michal Sheffer et al.   Oncotarget

Hypoxia-Induced Decrease in p53 Protein Level and Increase in c-jun DNA Binding Activity Results in Cancer Cell Resistance to Etoposide

(2015) Jean-Philippe Cosse et al.   NEOPLASIA

Tumour Hypoxia Affects the Responsiveness of Cancer Cells to Chemotherapy and Promotes Cancer Progression

(2012) Jean-Philippe Cosse et al.   Anti-Cancer Agents in Medicinal Chemistry

HIF-1α in Epidermis: Oxygen Sensing, Cutaneous Angiogenesis, Cancer, and Non-Cancer Disorders

(2011) Hamid R. Rezvani et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A close look at cancer

(2011) Alison Farrell   NATURE MEDICINE

RAB8 Enhances TMEM205-Mediated Cisplatin Resistance

(2011) Ding-Wu Shen et al.   PHARMACEUTICAL RESEARCH

Meta-analysis of archived DNA microarrays identifies genes regulated by hypoxia and involved in a metastatic phenotype in cancer cells

(2010) Michael Pierre et al.   BMC CANCER

HIF-1 and NDRG2 contribute to hypoxia-induced radioresistance of cervical cancer Hela cells

(2010) Junye Liu et al.   EXPERIMENTAL CELL RESEARCH

Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance

(2010) Ding-Wu Shen et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia

(2010) Lionel Flamant et al.   Molecular Cancer

The role of topoisomerase IIα and HER-2 in predicting sensitivity to anthracyclines in breast cancer patients

(2009) Catherine Oakman et al.   CANCER TREATMENT REVIEWS

Role of hypoxia in the hallmarks of human cancer

(2009) Kai Ruan et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target

(2009) Randy L. Jensen   JOURNAL OF NEURO-ONCOLOGY

Hypoxia prevents etoposide-induced DNA damage in cancer cells through a mechanism involving hypoxia-inducible factor 1

(2009) R. Sullivan et al.   MOLECULAR CANCER THERAPEUTICS

An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia

(2009) Yair Benita et al.   NUCLEIC ACIDS RESEARCH

Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-κB activity in hypoxic tumor cells

(2009) G -Y Jang et al.   ONCOGENE

Hypoxia upregulates the histone demethylase JMJD1A via HIF-1

(2008) Sven Wellmann et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Hypoxia-Inducible Factor-2  Correlates to Distant Recurrence and Poor Outcome in Invasive Breast Cancer

(2008) K. Helczynska et al.   CANCER RESEARCH

An overview of cancer multidrug resistance: a still unsolved problem

(2008) H. Lage   CELLULAR AND MOLECULAR LIFE SCIENCES

Targeting tumour hypoxia in breast cancer

(2008) Manuela Milani et al.   EUROPEAN JOURNAL OF CANCER

Hypoxia induces protection against etoposide-induced apoptosis: molecular profiling of changes in gene expression and transcription factor activity

(2008) Audrey Sermeus et al.   Molecular Cancer

RPN2 gene confers docetaxel resistance in breast cancer

(2008) Kimi Honma et al.   NATURE MEDICINE

Heparin-Binding EGF-Like Growth Factor Is Induced by Disruption of Lipid Rafts and Oxidative Stress in Keratinocytes and Participates in the Epidermal Response to Cutaneous Wounds

(2007) Conny Mathay et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY